Dr. Jeffrey A Norton
Claim this profileCharter Research - Lady Lake
Expert in Alzheimer's Disease
Studies Cognitive Impairment
24 reported clinical trials
26 drugs studied
Area of expertise
1Alzheimer's Disease
Global LeaderAPOE
APOE ε4 positive
ApoE positive
2Cognitive Impairment
APOE
Affiliated Hospitals
Clinical Trials Jeffrey A Norton is currently running
LY3305677
for Obesity
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.
Recruiting0 awards Phase 23 criteria
LY3954068
for Alzheimer's Disease
The main purpose of this study is to evaluate the safety of LY3954068 in participants with early symptomatic Alzheimer's Disease (AD). The study will also investigate how much LY3954068 gets into the bloodstream and will test the effects of LY3954068 on markers of AD. The study will be comprised of two parts, A and B. Each enrolled participant in Part A will receive a single dose of LY3954068 or placebo (no active drug) given into the spinal fluid. Each participant in Part B will receive 2 doses of either LY3954068 or placebo administered into the spinal fluid. Participants will have the opportunity to join an optional bridging period to a separate potential study where participants would receive LY3954068. The study will last up to approximately 45 weeks for Part A, and 100 weeks for Part B, including the screening period.
Recruiting0 awards Phase 1
More about Jeffrey A Norton
Clinical Trial Related2 years of experience running clinical trials · Led 24 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Jeffrey A Norton has experience with
- Placebo
- Donanemab
- LY3841136
- Aducanumab
- Blood-Based Biomarkers
- Digital Biomarkers
Breakdown of trials Jeffrey A Norton has run
Alzheimer's Disease
Cognitive Impairment
Dementia
Obesity
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeffrey A Norton specialize in?
Jeffrey A Norton focuses on Alzheimer's Disease and Cognitive Impairment. In particular, much of their work with Alzheimer's Disease has involved APOE patients, or patients who are APOE ε4 positive.
Is Jeffrey A Norton currently recruiting for clinical trials?
Yes, Jeffrey A Norton is currently recruiting for 3 clinical trials in Lady Lake Florida. If you're interested in participating, you should apply.
Are there any treatments that Jeffrey A Norton has studied deeply?
Yes, Jeffrey A Norton has studied treatments such as Placebo, Donanemab, LY3841136.
What is the best way to schedule an appointment with Jeffrey A Norton?
Apply for one of the trials that Jeffrey A Norton is conducting.
What is the office address of Jeffrey A Norton?
The office of Jeffrey A Norton is located at: Charter Research - Lady Lake, Lady Lake, Florida 32159 United States. This is the address for their practice at the Charter Research - Lady Lake.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.